Delivery Order SPE2DR25D1100-SPE2DR26FCN4F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Latuda 80 mg tablets (30-count units) with a ceiling value of $5,922.45. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a delivery order valued at $10,999.03 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count packages) on September 2, 2025, with a completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Latuda 60 mg tablets (30-count units) with a ceiling value of $29,470.00 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,787.95 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by May 7, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,755.09 to AmerisourceBergen Drug Corp for the supply of Latuda 20 mg tablets (30-count packaging) on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price contract, with no set-aside designation, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $50,064.71 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, issued on September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count packaging) under a firm fixed-price arrangement. The contract, valued at $7,553.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 29, 2025. AmerisourceBergen will perform fulfillment operations from its corporate office in Conshohocken, Pennsylvania, serving as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,694.31 to AmerisourceBergen Drug Corp for the supply of Latuda 60 mg tablets (30-count units). This firm fixed-price delivery order, issued on October 21, 2025, with completion targeted for October 22, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCN4FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,377.96 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count package) under a firm fixed-price contract. The award was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to provide specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/7/25 |